Lala Bhaj Bahadur,

Dy Minister of Foreign Affairs

 

What Shrimati Bose and Madhur have said is disturbing.  The US said that the change would mean huge foreign investments in the Indian pharmaceutical industry, enabling expansion and greater ability to provide for India's needs.  We did not expect that we might lose control of our pharmaceuticals, as we have with Ranboxy.  Nor that we might lose the industry altogether.   Historically, the percentage of allowable foreign direct investment in pharmaceuticals has varied from 38% to a recent 74%.    I'm not sure we are in a position to reverse ourselves at this point, but we might have to in the future.    Please keep us informed.  

 What globalization means is that we must change policies to fit with the western countries. 

When we made the decision, there was no opposition from the Indian Drug Manufacturing Association;  the editorial from Pharma-Biz came after the decision was made.  Of course, our deliberations were secret.     

On Africa, we have pledged to give a few million to the AIDS program.  Could we make it a gift in kind, and provide as  many doctors, nurses, and lab technicians that the money allocated can support?    I'd be willing to support such a move.  How will you persuade medical personnel to go?   We remember that shortly after independence several African governments asked those of Indian descent to leave the country.         

On another note, we did win a victory in the November 2001 WTO negotiations in Qatar.  States can purchase generic drugs--and not just for AIDS, but for cancer and other ailments.  That should boost the pharmaceutical industry in India, Brazil and Thailand.  

Ram Raj Tripathi

Prime Minister's Secretariat

Uma Shankar Bose, Dy. Minister of Chemicals and Pharmaceuticals

Bansi Lal Yadav, 

Dy. Minister of Health

 

Dr. Jayalitha Madhur

Indian Drug Manufacturer's Association Exec. Director